Riskpilot← Back to searchSign inGet full accessTandvård i C Vällingby AB
ABActiveOrg 5592169998Vällingby Torg 31Dental practice care activities · NACE 8623Est. 20195 employees
Revenue 2024
SEK 10,1M
-10% vs 2023
EBITDA margin
24.5%
0% vs 2023
Equity ratio
58.6%
Financial strength
Net profit 2024
SEK 1,4M
-30% vs 2023
| Revenue | SEK 10,1M | -10% |
| EBITDA | SEK 2,5M | +0% |
| Net profit | SEK 1,4M | -30% |
| Total assets | SEK 6,8M | +14% |
| Equity | SEK 4M | +11% |
| Employees | 5 | — |
Legal name
Tandvård i C Vällingby AB
Org number
5592169998
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
3 september 2019
Share capital
SEK 50 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Tandläkarklinik
Address
Vällingby Torg 31
Email
roweid.suliman@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 165 | 8 985 | 10 085 | 11 233 | 10 069 |
| Staff expenses | — | — | — | −3 060 | −3 261 |
| EBITDA | 373 | 2 833 | 2 734 | 2 462 | 2 464 |
| Depreciation & amort. | −31 | −109 | −167 | −131 | −167 |
| EBIT | 342 | 2 724 | 2 567 | 2 331 | 2 297 |
| Net financials | −1 | −81 | 6 | 70 | 80 |
| Profit before tax | 340 | 1 982 | 1 849 | 2 506 | 1 771 |
| Tax | −73 | −409 | −382 | −523 | −374 |
| Net profit | 267 | 1 573 | 1 467 | 1 984 | 1 397 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 395 | 3 727 | 6 136 | 5 970 | 6 803 |
| Equity | 317 | 1 891 | 2 792 | 3 580 | 3 988 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 2 078 | 1 175 | 1 959 | 1 112 | 931 |
| Total debt | 2 078 | 1 175 | 1 959 | 1 112 | 931 |
EBITDA margin
24.5%
This company
15.8%
Market median
+55% vs market
20202024
Equity ratio
58.6%
This company
38.2%
Market median
+53% vs market
20202024
Return on equity
35.0%
This company
18.4%
Market median
+90% vs market
20202024
Net profit margin
13.9%
This company
8.1%
Market median
+72% vs market
20202024
Asset turnover
1.48×
This company
1.12×
Market median
+32% vs market
20202024
Debt / equity
0.71×
This company
0.62×
Market median
+15% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KG Audit | Audit | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2025 | |
| Former (2) | ||
| Deputy Board Member | 2020 – 2025 | |
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Tandvård i C Vällingby AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Koray Göker | Audit | 0 companies |
| Roweid Suliman | Board of Directors | 0 companies |
| Filiz Öglü Södergren | Deputy Board Member | 0 companies |
| Paul Suliman | Deputy Board Member | 0 companies |
| Lusi Kastan | Deputy Board Member | 0 companies |